BJERKHOLT ERIC
SEC insider (Form 3/4/5 filer). CIK 0001197350. CHIEF FINANCIAL OFFICER at Mirum Pharmaceuticals, Inc. (MIRM) and 3 other issuers. 38 reported Form 4/5 transactions since Sep 2024; latest on Sep 14, 2026. Located in FOSTER CITY, CA.
Companies BJERKHOLT ERIC has filed insider reports for
- Mirum Pharmaceuticals, Inc. (MIRM): Officer, CHIEF FINANCIAL OFFICER
- CERUS CORP (CERS): Director
- Metagenomi Therapeutics, Inc. (MGX): Director
- Surrozen, Inc./DE (SRZN): Director
BJERKHOLT ERIC
CIK: 0001197350
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (38 total)
- Sep 14, 2026MIRM
Mirum Pharmaceuticals, Inc.
SaleDirect9.9K shares at avg. $98.37$978K - Sep 11, 2026MIRM
Mirum Pharmaceuticals, Inc.
ExerciseDirect18.3K shares- - Aug 11, 2026MIRM
Mirum Pharmaceuticals, Inc.
SaleDirect6K shares at avg. $99.90$600K - Jul 6, 2026MIRM
Mirum Pharmaceuticals, Inc.
SaleDirect1K shares at avg. $122.43$128K - Jul 6, 2026MIRM
Mirum Pharmaceuticals, Inc.
SaleDirect528 shares at avg. $123.84$65K - Jul 6, 2026MIRM
Mirum Pharmaceuticals, Inc.
SaleDirect300 shares at avg. $124.94$37K - Jul 6, 2026MIRM
Mirum Pharmaceuticals, Inc.
SaleDirect3.1K shares at avg. $121.67$380K - Jun 9, 2026CERS
CERUS CORP
SaleDirect20.5K shares at avg. $2.60$53K - Jun 9, 2026MGX
Metagenomi Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
21K shares- - Jun 9, 2026MIRM
Mirum Pharmaceuticals, Inc.
ExerciseDirect2.4K shares at avg. $26.49$63K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 14, 2026 |  MIRM Mirum Pharmaceuticals, Inc. | Sale | 9,943 | $98.37 | $978,093 | Direct |
| Sep 11, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Exercise | 18,333 | - | $0 | Direct |
| Aug 11, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale | 6,001 | $99.90 | $599,510 | Direct |
| Jul 6, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale | 1,048 | $122.43 | $128,307 | Direct |
| Jul 6, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale | 528 | $123.84 | $65,388 | Direct |
| Jul 6, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale | 300 | $124.94 | $37,482 | Direct |
| Jul 6, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale | 3,124 | $121.67 | $380,097 | Direct |
| Jun 9, 2026 |  CERS CERUS CORP | Sale | 20,454 | $2.60 | $53,180 | Direct |
| Jun 9, 2026 |  MGX Metagenomi Therapeutics, Inc. | Award Stock Option (Right to Buy) | 21,000 | - | - | Direct |
| Jun 9, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Exercise | 2,393 | $26.49 | $63,391 | Direct |
1-10 of 38 transactions